Syed Razvi, MD
Anesthesiology · Nashua, NHNPI 1659335081
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,383 of the $1,846 with a category attached, or 74.9%. Abbott accounts for 78.1% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $485 and has fallen 54.1% since, to $223 in 2025. Among anesthesiology clinicians in NH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 34 payments — averaging $54.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1K
- Boston Scientific$192
- Painteq LLC$95
- AbbVie$94
- Teva Pharmaceuticals USA, Inc.$12
- Pfizer$11
What the payments were for
- Food & beverage$1,38375%
- Education$46225%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 17 | $1,441 |
| Boston Scientific | 9 | $192 |
| Painteq LLC | 2 | $95 |
| AbbVie | 4 | $94 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
| Pfizer | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Axium INS DRG IPG$444
- ETERNA$317
- PRODIGY$113
How this compares
$1,846 in reported general payments places this provider in the 90th percentile of 237 anesthesiology providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 12 | $300 |
| Gabapentin | 24 | $221 |
| Meloxicam | 16 | $43 |
| Cyclobenzaprine Hcl | 20 | $24 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Nashua
- Brian KlaggesNashua$48K
- Joseph HyattNashua$2K
- Gabriela CalhounNashua$909
- Gary FriedmanNashua$498
- Jose Ossa-ConchaNashua$353
- Chun-Huai ChaoNashua$294
- Michael PedroNashua$280
- Scott LauerNashua$207
- Alex DresslerBedford$20K
- Rafael VazquezSalem$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.